1. Home
  2. SWTX vs FHB Comparison

SWTX vs FHB Comparison

Compare SWTX & FHB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SWTX
  • FHB
  • Stock Information
  • Founded
  • SWTX 2017
  • FHB 1858
  • Country
  • SWTX United States
  • FHB United States
  • Employees
  • SWTX N/A
  • FHB N/A
  • Industry
  • SWTX Biotechnology: Pharmaceutical Preparations
  • FHB Major Banks
  • Sector
  • SWTX Health Care
  • FHB Finance
  • Exchange
  • SWTX Nasdaq
  • FHB Nasdaq
  • Market Cap
  • SWTX 3.0B
  • FHB 3.3B
  • IPO Year
  • SWTX 2019
  • FHB 2016
  • Fundamental
  • Price
  • SWTX $47.41
  • FHB $24.29
  • Analyst Decision
  • SWTX Strong Buy
  • FHB Sell
  • Analyst Count
  • SWTX 5
  • FHB 8
  • Target Price
  • SWTX $72.40
  • FHB $28.25
  • AVG Volume (30 Days)
  • SWTX 2.0M
  • FHB 933.4K
  • Earning Date
  • SWTX 05-01-2025
  • FHB 04-25-2025
  • Dividend Yield
  • SWTX N/A
  • FHB 4.28%
  • EPS Growth
  • SWTX N/A
  • FHB N/A
  • EPS
  • SWTX N/A
  • FHB 1.79
  • Revenue
  • SWTX $191,589,000.00
  • FHB $793,791,000.00
  • Revenue This Year
  • SWTX $85.98
  • FHB $9.83
  • Revenue Next Year
  • SWTX $69.16
  • FHB $4.71
  • P/E Ratio
  • SWTX N/A
  • FHB $13.57
  • Revenue Growth
  • SWTX 3417.33
  • FHB N/A
  • 52 Week Low
  • SWTX $28.21
  • FHB $19.48
  • 52 Week High
  • SWTX $62.00
  • FHB $28.80
  • Technical
  • Relative Strength Index (RSI)
  • SWTX 44.48
  • FHB 37.03
  • Support Level
  • SWTX $45.88
  • FHB $23.95
  • Resistance Level
  • SWTX $51.43
  • FHB $25.38
  • Average True Range (ATR)
  • SWTX 2.12
  • FHB 0.66
  • MACD
  • SWTX -0.66
  • FHB 0.04
  • Stochastic Oscillator
  • SWTX 23.47
  • FHB 17.74

About SWTX SpringWorks Therapeutics Inc.

SpringWorks Therapeutics Inc is a clinical stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing highly prevalent, genetically defined cancers.

About FHB First Hawaiian Inc.

First Hawaiian Inc is a bank holding company. It provides a diversified range of banking services to consumer and commercial customers, including deposit products, lending services, and wealth management and trust services. The company offers a variety of deposit products to its customers, including checking and savings accounts and other types of deposit accounts. It provides commercial and industrial lending, including auto dealer flooring, commercial real estate, and construction lending. It also offers comprehensive consumer lending services focused on residential real estate lending, indirect auto financing, and other consumer loans. The company's segments are Retail Banking, Commercial Banking, and Treasury, and others of which key revenue is derived from Retail Banking.

Share on Social Networks: